Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Herceptin|DRUG: Capecitabine (Xeloda)
Sponsor: Hellenic Oncology Research Group
Collaborators: University Hospital of Crete